4 Results for "

HepDE19

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "HepDE19" in MCE Product Catalog:

Cat. No.: HY-148348
CAS No.: 2445597-31-7
Purity:  99.13%
Target:  

HBV

Research Areas:  

Infection

AB-836 is an orally active HBV capsid inhibitor. AB-836 inhibits viral replication by interacting with HBV core protein. AB-836 can be used in research related to chronic hepatitis B .
loading...
    loading...
Cat. No.: HY-168045
CAS No.: 2743466-04-6
Target:  

HBV DNA/RNA Synthesis

Research Areas:  

Infection

HBV-IN-48 is an HBV inhibitor. HBV-IN-48 has antiviral activity against HBV in HepDE19 cells, with an EC50 value of 0.005 μM. HBV-IN-48 can reduce serum HBV DNA levels in mouse models of HBV infection .
loading...
    loading...
Cat. No.: HY-122209
CAS No.: 330461-34-2
Target:  

HBV

Research Areas:  

Infection

DVR-01 is a HBV inhibitor with EC50 values of 1.7 and 1.6 μM in AML12HBV10 and HepDES19 cells, respectively. DVR-01 shows antiviral activity against drug-resistant HBV mutants with EC50s of 2.403-3.273 μM. DVR-01 can be used for the research of HBV infection and related diseases .
loading...
    loading...
Cat. No.: HY-180524
CAS No.: 3014372-17-6
Target:  

HBV

Research Areas:  

Infection

CAB7-3 is an orally active HBV capsid assembly modulator (CAM). CAB7-3 exhibits an exceptional antiviral efficacy reducing HBV DNA with an EC50 = 70 nM, CC50 = 32.3 μM in HepDES19 cells. CAB7-3 exhibits significant anti-HBV activity in HBV-integrated HepDES19 (EC50 = 70 nM), HepAD38 (EC50 = 1 nM) and HBV-infected HLCZ01 cells (EC50 = 2 nM), respectively. CAB7-3 effectively reduces Hepatic HBV core protein levels and suppresses viral replication in vivo. CAB7-3 demonstrates a favorable drug-like and safety profile. CAB7-3 can be used for Hepatitis B Virus (HBV) research .
loading...
    loading...